ACE and COVID-19: These data add to our mechanistic understanding of COVID-19 and prompted us to hypothesize the existence of an unidentified enzymatic degradation of angiotensin II (in addition to ACE2) or the presence of an unidentified intrinsic functional inhibitor of ACE.